Erythrocin Lactobionate Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-6482

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Erythrocin Lactobionate (NDC 0409-6482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula Erythromycin Lactobionate (Erythrocin 01)

Chemical structure diagram of erythromycin lactobionate, showing its molecular arrangement with various functional groups and carbon chains.*

FDA Label Image

Logo (Erythrocin 01a)

FDA Label Image

Principal Display Panel (500 mg Vial Label)

Label for Erythrocin Lactobionate Injection, USP, sterile powder for intravenous injection by Hospira, Inc. The label indicates 500 mg erythromycin activity per vial, benzyl alcohol free formula, NDC 0409-6482, with instructions for dilution and storage.*

FDA Label Image

Logo (Erythrocin 02a)

FDA Label Image

Principal Display Panel (500 mg Vial Tray)

Label for Erythrocin Lactobionate Injection, Powder, Lyophilized, for Solution, 500 mg per vial by Hospira, Inc. The label indicates the product is for intravenous use only and is benzyl alcohol free. It includes pharmacy preparation notes for dilution, prescription only status, and packaging for ten vials of sterile powder.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.